-
Product Insights
NewLikelihood of Approval Analysis for Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Overview How likely is it that the drugs in Coronary Artery Disease (CAD) (Ischemic Heart Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Coronary Artery Disease (CAD) (Ischemic Heart Disease)...
-
Product Insights
NewLikelihood of Approval Analysis for Atherosclerosis
Overview How likely is it that the drugs in Atherosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atherosclerosis Overview Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries...
-
Product Insights
NewLikelihood of Approval Analysis for Myelofibrosis
Overview How likely is it that the drugs in Myelofibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Myelofibrosis Overview Myelofibrosis is a rare bone marrow disorder where abnormal cells cause...
-
Product Insights
NewLikelihood of Approval Analysis for Lipid Disorders
Overview How likely is it that the drugs in Lipid Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Disorders Overview Abnormal levels of triglycerides and LDL in the blood....
-
Product Insights
NewLikelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
NewLikelihood of Approval Analysis for Occlusive Arterial Disease (OAD)
Overview How likely is it that the drugs in Occlusive Arterial Disease (OAD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Occlusive Arterial Disease (OAD) Overview Occlusive arterial disease (OAD), also...
-
Product Insights
NewLikelihood of Approval Analysis for Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that the drugs in Plaque Psoriasis (Psoriasis Vulgaris) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plaque Psoriasis (Psoriasis Vulgaris) Overview Plaque psoriasis, also known as...
-
Product Insights
NewLikelihood of Approval Analysis for IgA Nephropathy (Berger’s Disease)
Overview How likely is it that the drugs in IgA Nephropathy (Berger's Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IgA Nephropathy (Berger's Disease) Overview IgA nephropathy, also known as...
-
Product Insights
NewLikelihood of Approval Analysis for Renal Failure
Overview How likely is it that the drugs in Renal Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Renal Failure Overview Renal failure, or kidney failure, occurs when the kidneys...
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Artery Occlusive Disease (PAOD)
Overview How likely is it that the drugs in Peripheral Artery Occlusive Disease (PAOD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Artery Occlusive Disease (PAOD) Overview Peripheral artery occlusive...